
Hypen Max SR1.5 mg+5 m
Opsonin Pharma Ltd.
Indapamide + Amlodipine is a fixed-dose combination indicated for the treatment of essential hypertension.
Indapamide + Amlodipine is a fixed-dose combination indicated for the treatment of essential hypertension. It combines a thiazide-like diuretic (indapamide) with a dihydropyridine calcium channel blocker (amlodipine), two agents with complementary mechanisms of blood pressure lowering.
| Indication | Typical Dose |
|---|---|
| Substitution therapy in patients already controlled on individual components | One tablet once daily of the strength matching the individually-titrated doses of indapamide and amlodipine |
| Combination therapy after monotherapy titration | One tablet once daily, typically taken in the morning, once the individual component doses have been established by the prescriber |
Indapamide + Amlodipine is contraindicated in severe renal impairment (see Contraindications). In mild-to-moderate renal impairment, use with caution and monitor renal function and electrolytes.
Indapamide + Amlodipine is contraindicated in severe hepatic impairment or hepatic encephalopathy (see Contraindications). Amlodipine should be initiated at the lower end of the dosing range in hepatic impairment; a physician should assess whether the fixed-dose combination is appropriate.
No dose adjustment of the combination is generally required in the elderly, but they are at greater risk of electrolyte disturbances and should be monitored closely; see Use in Special Populations.
Side effects of Indapamide + Amlodipine reflect those reported with each component.
Patients should seek prompt medical attention for signs of severe allergic reaction, irregular heartbeat, severe dizziness, or unusual muscle weakness/cramping (possible electrolyte disturbance).
Indapamide + Amlodipine is contraindicated in patients with:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.